PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS
The Pharma Data
MAY 4, 2021
PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS. First-Quarter 2021 Revenues of $14.6 Billion, Reflecting 42% Operational Growth; Excluding Revenues for BNT162b2 of $3.5 Billion, Revenues Grew 8% Operationally Including a Negative 5% Impact from Pricing. Maintains Quarterly Dividend for Second-Quarter 2021 at $0.39/Share;
40 
Let's personalize your content